DEPODUR

Compare DEPODUR  to:
Compare
Compare

Generic Name for DEPODUR

Morphine sulfate 10mg/mL; ext-rel liposomal susp for epidural inj; preservative free.

Legal Classification:

CII

Pharmacological Class for DEPODUR

Opioid.

Manufacturer of DEPODUR

EKR Therapeutics. Inc.

Indications for DEPODUR

Post-op pain after major surgery.

Adult dose for DEPODUR

≥18yrs: Give as a single dose by lumbar epidural inj only, before surgery or after clamping umbilical cord in caesarean section. Individualize. Monitor closely for at least 48 hrs after dosing. Orthopedic surgery (lower extremities): 15mg. Lower abdominal or pelvic surgery: 10–15mg. Caesarean section: 10mg. All: max 20mg.

Children's dosing for DEPODUR

<18 yrs: not recommended.

Contraindications for DEPODUR

Head injury. Increased intracranial pressure. Respiratory depression. Asthma. Upper airway obstruction. Paralytic ileus. Circulatory shock.

Warnings/Precautions for DEPODUR

Conditions that increase risk of respiratory depression (eg, hypercapnia, obesity, surgery cancellation). Impaired myocardial function. Volume depletion. Biliary tract disease. Acute pancreatitis. Seizure disorders. GI or GU obstruction. Drug abusers. Elderly. Debilitated. Labor & delivery (not for use in vaginal delivery). Pregnancy (Cat.C). Nursing mothers.

Interactions for DEPODUR

During or within 14 days of MAOIs: not recommended. Epidural local anesthetics: allow ≥15 minutes between test dose of lidocaine and epinephrine and DepoDur inj; allow ≥30 minutes between analgesic dose of bupivacaine and Depodur inj. Suspend use of other epidural drugs for at least 48 hrs. Potentiated by other CNS depressants (eg, alcohol, other opiates, general anesthetics, sedatives, antihistamines, phenothiazines). Potentiates neuromuscular blockers.

Adverse Reactions for DEPODUR

CNS and respiratory depression, orthostatic hypotension, urinary retention, GI upset, constipation, paralytic ileus, pruritus, pyrexia, anemia, headache, dizziness, biliary colic, bladder spasm, bradycardia, tachycardia, back pain.

Notes for DEPODUR

Be fully experienced in the administration of epidural drugs. Have resuscitative equipment and narcotic antagonists immediately available.

How is DEPODUR supplied?

Single-use vials (1mL, 1.5mL)—5

Related Disease:

Pain, general~narcotics

Related Resources

Butrans transdermal system approved for chronic pain

July 01, 2010

The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time.

CDC issues statement and recommendations regarding prescription drug misuse

June 04, 2010

The CDC announced the 2009 National Youth Risk Behavior Survey (YRBS) found that 1 in 5 high school students have ever taken a prescription drug such as OxyContin (oxycodone, from Purdue), Percocet (oxycodone/acetaminophen, from Endo), Vicodin (hydrocodone/acetaminophen, from Abbott), Adderall (mixed salts of a single-entity amphetamine product, from Shire), Ritalin (methylphenidate, from Novartis), or Xanax (alprazolam, from Pfizer), without a prescription.

Phase 2 study of ARX-02 sufentanil NanoTab for cancer breakthrough pain

May 25, 2010

AcelRx Pharmaceuticals announced positive results from a Phase 2 clinical study evaluating the safety and efficacy of its ARX-02 sufentanil NanoTab Breakthrough Pain Management System in the treatment of cancer breakthrough pain in opioid-tolerant patients.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.

Covidien launches Exalgo for chronic pain relief

April 26, 2010

Exalgo (hydromorphone HCl extended-release tablets) has been launched by Covidien for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions